| Code | 4938D | ||||||||||
| MA number | 59/0150/20-S | ||||||||||
| Product Form: | cps dur 98x0,5 mg (blis.OPA/Al/PVC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Vipharm S.A., Poland | ||||||||||
| Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister OPA/Al/PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 21.07.2020 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_FIMODIGO 0,5 mg_10.2024.pdf
|
| PIL: |
PIL_FIMODIGO 0,5 mg_10.2024.pdf
|
| Safety feature | Yes |
| Data update: | 21.03.2025 |
